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1. Introduction 
Anticoagulant rodenticides are used globally to control pest rodent infestations due to their efficacy and ease 
of use. Resistance to anticoagulant rodenticides first appeared against warfarin and diphacinone in Scotland 
in 1958 [1]. In the wake of this, more potent anticoagulant rodenticides were produced but resistance has 
since developed to some of these [2]. Monitoring of residue levels in predators and scavengers in the UK 
has shown that anticoagulant rodenticide exposure affects a range of non-target species, including some of 
high conservation value [3]. The risk to a non-target species will depend on its exposure to anticoagulant 
rodenticides in the diet and its susceptibility to the anticoagulant rodenticide. However, the impact of 
resistance on dietry exposure is not well understood, although it is predicted to increase exposure to non-
target species [4]. The aim of our work was to explore the level of anticoagulant rodenticide uptake into 
rodenticide-resistant rat populations during rodent-control trials in Germany and the UK using three different 
anticoagulant rodenticide compounds, and to assess the relative risks to non-target species as a result. We 
show that rodenticide-resistance can affect both population control and bait uptake and that rodenticide-
resistant areas could be a particular hazard with regard to non-target exposure. 
2. Materials and methods 
Field trials of three anticoagulant rodenticides (brodifacoum, bromadiolone and difenacoum) were conducted 
on farms in North-west Germany and Southern England between 2005 and 2010 where resistance to 
bromadiolone and difenacoum in Norway rats (Rattus norvegicus) was confirmed. Rat population censuses 
were carried out pre- and post-baiting. Anticoagulant rodenticide baits were applied according to product 
labels, pulsed-baiting was used for brodifacoum and surplus baiting for bromadiolone and difenacoum [5]. All 
baits contained 0.005% w/w of the respective active substances. Models were created utilising the data 
obtained from these trials to predict the amounts of the anticoagulant rodenticide active substances in 
different environmental compartments through the course of the trials. The daily uptake of bait was modelled 
along with the predicted rat population size and thus the level of active substance in different sectors of the 
rat population could be predicted. Based on the natural history of the species of interest, the relative 
exposure to different compounds in non-target species as a result of these field trials was quantified. 
3. Results and discussion 
3.1. Comparing trial efficacy 
Across all trials brodifacoum was the most effective compound reducing rat populations to less than 1% of 
their original size on all farms. Bromadiolone and difenacoum had lower rates of success as would be 
expected in resistant areas. Control was inversely proportional to the amount of active substance (a.s.) 
entering the food chain. 
3.2. Anticoagulant rodenticide levels in the rat population 
Our model showed that bromadiolone and difenacoum use in these trials resulted in much higher levels of 
a.s. entering the food chain via the rats than the use of brodifacoum (Fig. 1). It also showed that a.s. 
continued to enter the rat population at a much higher rate throughout the trials where control was less 
effective. The model predicted that after the end of baiting, rats carried residues of bromadiolone and 
difenacoum until the end of their natural life. However, no brodifacoum baited rats were predicted to be alive 
at the end of the trials.  
 
Figure 1. 
Mean (± S.E.) loading of active substance present in the rat population over the whole farm throughout the 
trials. Baiting was with either: bromadiolone (n=6), difenacoum (n=4) or brodifacoum (n=2). Bromadiolone 
and difenacoum trials showed much higher uptakes over the course of the trials than brodifacoum trials. 
3.3. Anticoagulant rodenticide levels in the non-target population 
Modelling secondary non-target uptake in these scenarios shows that higher residue levels in the rat 
population and higher numbers live rats in the environment increase exposure and increase the chance of 
lethality to the non-target. 
4. Conclusions 
The use of potent anticogulant rodenticide ‘resistance-breakers’ is avoided due to their higher toxicity and 
potential to be more hazardous in the environment [6]. However, in areas where practitioners seek to control 
resistant rodent infestations, their use may pose less of a risk than applications of ineffective baits. 
Compounds to which rodents are resistant to, do not provide effective control and create a long-term source 
of AR in the environment. The higher quantities of anticoagulant rodenticide used show that using ineffective 
compounds may extend both the period and severity of exposure to non-target animals to anticoagulant 
rodenticides. Conversely the effective use of resistance-breakers to control anticoagulant rodenticide-
resistant rat populations results in lower environmental exposure of anticoagulant rodenticides for non-
targets. Of course, the relative toxicity of the different anticoagulant rodenticides will also play an important 
part in overall risk assessments. However, this can be outweighed by the relative exposure to different 
anticoagulant rodenticides in such situations. 
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